HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Timing of gangrene tissue debridement after autologous bone marrow cell implantation in patients with superficial femoral arterial occlusion: preliminary experiences.

AbstractAIM:
Although implantation of bone marrow mononuclear cells (BMI) was shown to improve outcomes in patients with severe peripheral arterial occlusive disease (PAOD), little experience has been reported in patients with an arterial occlusion level above the knee, ischemic gangrene, and high cardiovascular risk. This study sought to investigate the timing of gangrene tissue debridement and the safety of BMI in these patients.
METHODS:
Six "no-option" PAOD patients were enrolled with an arterial occlusion level above the knee, ischemic gangrene, and 3 systemic diseases related to a high cardiovascular risk. The ischemic status was evaluated by measuring the ankle-brachial index (ABI), transcutaneous oxygen pressure (TcPO2), and wound healing after BMI.
RESULTS:
All patients safely underwent the procedures with intravenous general anesthesia by titrating propofol. Major lower extremity amputation, minor debridement amputation, and debridement surgery were performed in 2 (33.3%), 1 (16.7%), and 2 (33.3%) patients, respectively, 3.1 2.8 months after BMI. Compared to the amputation group (N=3), the salvage group (N=3) had a significantly higher baseline ABI (P=0.02) and a shorter distance between the gangrene site and arterial occlusion site (P=0.01). In the 3 patients who underwent debridement, ABI and TcPO2 significantly improved 1 month after BMI, and gangrenous tissues were debrided 3.8 ± 3.6 (range, 1~8) months after BMI with complete healing within 1 month.
CONCLUSION:
Autologous BMI therapy is safe in patients at high cardiovascular risk with an arterial occlusion level above the knee and ischemic gangrene. Effective predictors of BMI include the baseline ABI and distance to the ischemia. Gangrene tissue should be debrided at least 1 month after BMI.
AuthorsC H Wang, Y J Lan, C H Yeh, Y T Ng, P V H Chung, C M Hsu, L T Kuo, R E Huang, M H Liu, W J Cherng
JournalThe Journal of cardiovascular surgery (J Cardiovasc Surg (Torino)) Vol. 53 Issue 4 Pg. 507-16 (Aug 2012) ISSN: 1827-191X [Electronic] Italy
PMID22071470 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Aged
  • Amputation, Surgical
  • Analysis of Variance
  • Angiography, Digital Subtraction
  • Ankle Brachial Index
  • Arterial Occlusive Diseases (complications, diagnosis, surgery)
  • Blood Gas Monitoring, Transcutaneous
  • Bone Marrow Transplantation (adverse effects)
  • Cardiovascular Diseases (etiology)
  • Constriction, Pathologic
  • Debridement (adverse effects)
  • Female
  • Femoral Artery (diagnostic imaging, surgery)
  • Gangrene
  • Humans
  • Ischemia (diagnosis, etiology, surgery)
  • Limb Salvage
  • Lower Extremity (blood supply, pathology, surgery)
  • Male
  • Middle Aged
  • Pilot Projects
  • Radionuclide Imaging
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index
  • Taiwan
  • Time Factors
  • Transplantation, Autologous
  • Treatment Outcome
  • Wound Healing

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: